Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6407522 | 1.00 | MAOB (0.68) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL12992717 | 1.00 | MAOB (0.68) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL19956847 | 0.90 | MAOB (0.70) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| Benzene SCHEMBL135524 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL5875512 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL23458007 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL592744 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| Benzene SCHEMBL9803304 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL6853572 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 | |
| SCHEMBL718317 | 0.82 | MAOB (1.00) | MAOBMAPK1ALDH1A1LMNATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091608-B2 | Elastomeric composition and vulcanization accelerator used therein | PIRELLI TYRE S.P.A. (IT) | 2021-08-17 | — | — | US | disclosed |
| EP-3397678-B1 | ELASTOMERIC COMPOSITION AND VULCANIZATION ACCELERATOR USED THEREIN | PIRELLI (IT) | 2021-07-28 | — | — | EP | disclosed |
| US-20210179821-A1 | ELASTOMERIC COMPOSITION AND VULCANIZATION ACCELERATOR USED THEREIN | PIRELLI TYRE S.P.A. (IT) | 2021-06-17 | — | — | US | disclosed |
| CN-108463499-B | Elastomer composition and vulcanization accelerator used therein | 倍耐力轮胎股份公司 | 2020-03-10 | — | — | CN | disclosed |
| EP-3397678-A1 | ELASTOMERIC COMPOSITION AND VULCANIZATION ACCELERATOR USED THEREIN | Pirelli Tyre S.p.A. (IT) | 2018-11-07 | — | — | EP | disclosed |
| WO-2017115253-A1 | ELASTOMERIC COMPOSITION AND VULCANIZATION ACCELERATOR USED THEREIN | PIRELLI TYRE S.P.A. (IT) | 2017-07-06 | — | — | WO | disclosed |
| US-9399652-B2 | Synthetic route to pactamycin and pactamycin analogs | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2016-07-26 | — | — | US | disclosed |
| US-20150329570-A1 | SYNTHETIC ROUTE TO PACTAMYCIN AND PACTAMYCIN ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-11-19 | — | — | US | disclosed |
| US-8759007-B2 | Method to produce a receptor chip using biotinylated protein | NATIONAL FOOD RESEARCH INSTITUTE (JP) | 2014-06-24 | — | — | US | disclosed |
| US-8318085-B2 | Methods and compositions for inhibiting metal corrosion | HALLIBURTON ENERGY SERVICES, INC. (US) | 2012-11-27 | — | — | US | disclosed |
| EP-1689911-A1 | METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION | Halliburton Energy Services, Inc. (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005054544-A1 | METHODS AND COMPOSITIONS FOR INHIBITING METAL CORROSION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2005-06-16 | — | — | WO | disclosed |
| US-20050123437-A1 | Methods and compositions for inhibiting metal corrosion | HALLIBURTON ENERGY SERVICES, INC. | 2005-06-09 | — | — | US | disclosed |
| US-20040209294-A1 | Method to produce a receptor chip using biotinylated protein | NATIONAL FOOD RESEARCH INSTITUTE (JP) | 2004-10-21 | — | — | US | disclosed |
| US-5426143-A | Optical data storage films containing non-liquid crystalline polymer and infrared-activated dye either mixed with or covalently bonded to polymer | AKZO NOBEL N.V. (NL) | 1995-06-20 | — | — | US | disclosed |
| EP-0608019-A1 | Thermochromic infrared dyes | Akzo Nobel N.V. (NL) | 1994-07-27 | — | — | EP | disclosed |
| US-4196291-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1980-04-01 | — | — | US | disclosed |
| US-4141978-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-02-27 | — | — | US | disclosed |
| US-4113867-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1978-09-12 | — | — | US | disclosed |
| US-4001411-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329570-A1 | SYNTHETIC ROUTE TO PACTAMYCIN AND PACTAMYCIN ANALOGS | PAICS, DPM1, MANBA | MAOB 1503/4885MAPK1 1124/4885ALDH1A1 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.